MYM.CN - MYM Nutraceuticals Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 549.03M
Enterprise Value 348.09M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)78.42
Price/Book (mrq)2.47
Enterprise Value/Revenue 376.92
Enterprise Value/EBITDA 6-4.24

Trading Information

Stock Price History

Beta (3Y Monthly) 0.76
52-Week Change 3-69.47%
S&P500 52-Week Change 36.80%
52 Week High 31.4800
52 Week Low 30.2300
50-Day Moving Average 30.3450
200-Day Moving Average 30.4840

Share Statistics

Avg Vol (3 month) 3417.08k
Avg Vol (10 day) 3879.15k
Shares Outstanding 5125.72M
Float 113.81M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jun 14, 2019) 4107.48k
Short Ratio (Jun 14, 2019) 40.2
Short % of Float (Jun 14, 2019) 4N/A
Short % of Shares Outstanding (Jun 14, 2019) 40.04%
Shares Short (prior month May 15, 2019) 482.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends May 31, 2018
Most Recent Quarter (mrq)Feb 28, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,870.51%

Management Effectiveness

Return on Assets (ttm)-36.10%
Return on Equity (ttm)-73.58%

Income Statement

Revenue (ttm)625.21k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.16M
EBITDA -11.36M
Net Income Avi to Common (ttm)-13.7M
Diluted EPS (ttm)-0.1290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.98M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.88
Book Value Per Share (mrq)0.16

Cash Flow Statement

Operating Cash Flow (ttm)-9.93M
Levered Free Cash Flow (ttm)-12.74M